Details for New Drug Application (NDA): 210307
✉ Email this page to a colleague
NDA 210307 describes HYDROCORTISONE VALERATE, which is a drug marketed by Cosette, Encube Ethicals, Glenmark Pharms Ltd, Lupin Ltd, Padagis Israel, Taro, and Fougera Pharms, and is included in eleven NDAs. It is available from six suppliers. Additional details are available on the HYDROCORTISONE VALERATE profile page.
The generic ingredient in HYDROCORTISONE VALERATE is hydrocortisone valerate. There are sixty-seven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the hydrocortisone valerate profile page.
The generic ingredient in HYDROCORTISONE VALERATE is hydrocortisone valerate. There are sixty-seven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the hydrocortisone valerate profile page.
Summary for 210307
| Tradename: | HYDROCORTISONE VALERATE |
| Applicant: | Lupin Ltd |
| Ingredient: | hydrocortisone valerate |
| Patents: | 0 |
Pharmacology for NDA: 210307
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Suppliers and Packaging for NDA: 210307
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| HYDROCORTISONE VALERATE | hydrocortisone valerate | CREAM;TOPICAL | 210307 | ANDA | Lupin Pharmaceuticals, Inc. | 68180-954 | 68180-954-01 | 1 TUBE in 1 CARTON (68180-954-01) / 15 g in 1 TUBE |
| HYDROCORTISONE VALERATE | hydrocortisone valerate | CREAM;TOPICAL | 210307 | ANDA | Lupin Pharmaceuticals, Inc. | 68180-954 | 68180-954-02 | 1 TUBE in 1 CARTON (68180-954-02) / 45 g in 1 TUBE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CREAM;TOPICAL | Strength | 0.2% | ||||
| Approval Date: | Aug 15, 2019 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
